References
- Bradford PA. Extended spectrum I3-lactamases in the 21” century: characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933–951.
- Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedeman R. Evolution of plasmid coded resistance to broad spectrum cephalosporins. Antimicrob Agents Chemother 1985; 28: 303–307.
- Turner PJ. Extended spectrum I3-lactamases. Clin Infect Dis 2005; 41: S273–S275.
- Bush K, Singer SB. Biochemical characterization of extended spectrum I3-lactamases. Infection 1989; 17: 429–433.
- Paterson DL, Ko W-C, Von Gottberg, et al. Outcome of cephalosporin treatment for serious infections due to appar-ently susceptible organisms producing extended spectrum 13-lactamases. J Clin Microbiol 2001; 39; 2206-2212.
- Tenover FC, Mohammed MJ, Gorton TS, Demzek ZF. Detection and reporting of organisms producing extended-spectrum beta-lactamases: survey of laboratories in Connecticut. J Clin Microbiol 1999; 37: 4065–4070.
- Linscott AJ, Brown WJ. Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confir-mation tests. J Clin Microbiol 2005; 43: 1081–1085.
- West PWJ. Extended spectrum I3-lactamase producing Klebsiella spp. Br J Biomed Sci 2000; 57: 226–233.
- De Gheldre Y, Avesabi V, Berhin C, Delmee M, Glupczynski Y. Evaluation of Oxoid combination discs for the detection of extended spectrum I3-lactamases. J Antimicrob Chemother 2003; 52: 591–597.
- Jamal W, Rotimi VO, Khodakhast F, Saleem R, Pazhoor A, Al-Hashim G: Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the Vitek 2 and E test systems in a Kuwait teaching hospital. Med Princ Prac 2005; 14: 325–331.
- Rodriguez-Bano J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended spectrum beta-lactamase producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004; 42: 1089–1094.
- Nemoy LL, Kotetishvili, Tigno J, et al. Multilocus sequence typing versus pulsed-field gel electrophoresis for characterization of extended-spectrum beta-lactamase produc-ing Escherichia coli isolates. J Clin Microbiol 2005: 43: 1776–1781.
- Sawan RMZ, Jesuraj L, West P, Al-Saleh Q. Bacterial sepsis in Farwania neonatal unit - Kuwait. J Kwt Med Assoc 1997; 29: 291–296.
- Dashti AA, Paten P, Amyes SG. Linkage of ciprofloxacin resistance with a single genotypic cluster of Klebsiella pneumoniae. Int J Antimicrob Agents. 2006; 27 (1): 73–6.
- National Committee for Clinical Laboratory Standards. Approved standard M2-A8. Performance standards for antimi-crobial disc susceptibility tests. 2003 8th ed. NCCLS, Wayne PA.
- Nüesch-Inderbinen, MT, Hachler H, Kayser FH. Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method,and comparison with the E test. Eur J Clin Microbiol Infect Dis 1996; 15: 398–402.
- Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis. J Clin Microbiol 1995; 33: 2233–2239.
- Vercauteren E, Desceemaeker P, Ieven M, Sanders CC, Goosens H. Comparison of screening methods for the detec-tion of extended-spectrum I3-lactamases and their prevalence amongst blood culture isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. J Clin Microbiol 1997; 35: 2191–2197.